Tox21_202458

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

15 Suppliers, 6 USDMF, 4 CEP/COS, 2 JDMF, 3 EU WC, 10 NDC API, 11 Listed Suppliers

DEVELOPMENTS

32 Drug(s) in Development

32 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

1 Suppliers

1 Suppliers

DOSSIERs // Finished Dosage Forms

326 Dossiers, 118 FDA Orange Book, 106 Europe, 15 Canada, 31 Australia, 18 South Africa, 38 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG, TABLET;ORAL - 2MG, TABLET;ORAL - 5MG, GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 2.5MG/0.5ML (5MG/ML), GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 27 Roquette, 14 BASF, 13 Microlex e.U, 11 Sigachi Industries, 10 Gangwal Healthcare, 10 Corel Pharma Chem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Nanjing Well Pharmaceutical, 7 Seppic, 7 DFE Pharma, 6 SPI Pharma, 6 Gangwal Chemicals, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ideal Cures Pvt Ltd, 5 Vasa Pharmachem, 4 Prachin Chemical, 4 Actylis, 4 Ingredion Pharma Solutions, 3 Kima Chemical, 3 Finar, 2 Seqens, 2 The Dow Chemical Company, 2 Clariant, 2 Pharmatrans-Sanaq, 2 Nomisma Healthcare, 1 Jai Radhe Sales, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 ACG Worldwide, 1 Qualicaps, 1 Rochem International Inc, 1 DKSH, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 28 Disintegrants & Superdisintegrants, 26 Controlled & Modified Release, 26 Direct Compression, 19 Thickeners and Stabilizers, 18 Lubricants & Glidants, 18 Film Formers & Plasticizers, 18 Granulation, 15 Topical, 13 Taste Masking, 12 Co-Processed Excipients, 9 Parenteral, 8 Chewable & Orodispersible Aids, 8 Solubilizers, 5 Empty Capsules, 4 Emulsifying Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

32 US Medicaid Prescriptions, 113 Finished Drug Prices

MARKET PLACE

27 APIs, 24 DOSSIERS // FDF

PATENTS

18 US Patents, 3 US Exclusivities, 1 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 2 USP Standards, 10 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 66 News

Information, Expiry & Status of FDA Orange Book Patents covering Tox21_202458

Tox21_202458

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

15 Suppliers

6 USDMF

4 CEP/COS

2 JDMF

3 EU WC

10 NDC API

11 Listed Suppliers

DEVELOPMENTS

32 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

1 Suppliers

DOSSIERs // Finished Dosage Forms

326 Dossiers

118 FDA Orange Book

106 Europe

15 Canada

31 Australia

18 South Africa

38 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG

TABLET;ORAL - 2MG

TABLET;ORAL - 5MG

GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;RECTAL - 2.5MG/0.5ML (5MG/ML)

GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

27 Roquette

14 BASF

13 Microlex e.U

11 Sigachi Industries

10 Gangwal Healthcare

10 Corel Pharma Chem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Nanjing Well Pharmaceutical

7 Seppic

7 DFE Pharma

6 SPI Pharma

6 Gangwal Chemicals

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Ideal Cures Pvt Ltd

5 Vasa Pharmachem

4 Prachin Chemical

4 Actylis

4 Ingredion Pharma Solutions

3 Kima Chemical

3 Finar

2 Seqens

2 The Dow Chemical Company

2 Clariant

2 Pharmatrans-Sanaq

2 Nomisma Healthcare

1 Jai Radhe Sales

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 ACG Worldwide

1 Qualicaps

1 Rochem International Inc

1 DKSH

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders

47 Coating Systems & Additives

28 Disintegrants & Superdisintegrants

GEL;RECTAL - 10MG/2ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

GEL;RECTAL - 15MG/3ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

GEL;RECTAL - 20MG/4ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

GEL;RECTAL - 5MG/ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons